Abramowitz P W, Godwin H N, Latiolais C J, McDougal T R, Miller W A, Ravin R L
Hosp Formul. 1985 Oct;20(10):1071-2, 1078-81, 1086 passim.
The changes in health care have had a direct impact on the functions of the P & T Committee. P & T Committee members must be prepared to face new issues, especially concerning cost-effective drug therapy. Formulary admissions and use of nonformulary agents are discussed. The role of the P & T Committee in relation to the various hospital committees, the roles of physicians and pharmacists, and the role of the pharmacy director as manager are identified. Advice regarding standardization of therapy and drug-dosing policies is provided.